<p>儘管已經有了強勁的表現，<strong>Vita Coco Company, Inc.</strong>（納斯達克代碼：COCO）的股票仍在持續上漲，過去三十天上漲了 25%。回顧更長的時間段，令人鼓舞的是，過去一年該股票上漲了 50%。</p>
<p>在價格大幅反彈後，考慮到美國近一半的公司市盈率（或稱&#34;P/E&#34;）低於 18 倍，你可能會考慮完全避免投資 Vita Coco Company，因為其市盈率為 44 倍。不過，僅僅根據市盈率來判斷並不明智，因為可能有解釋其如此高的原因。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p>Vita Coco Company 的盈利增長優於最近大多數其他公司，表現相對良好。市盈率之所以可能較高，是因為投資者認為這種強勁的盈利表現將會持續。如果不是，那麼現有股東可能會對股價的可持續性感到有些緊張。</p>
<p>查看我們對 Vita Coco Company 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/29328309-pe-multiple-vs-industry-1-dark-2/1764505189784?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/29328309-pe-multiple-vs-industry-1-dark-2/1764505189784"/></p>
<p>納斯達克 GS:COCO 市盈率與行業比較 2025 年 11 月 30 日</p>
<p>想知道分析師如何看待 Vita Coco Company 的未來與行業的對比嗎？在這種情況下，我們的 <strong>免費</strong> 報告是一個很好的起點。</p>
<h2>增長指標告訴我們關於高市盈率的什麼？</h2>
<p>為了證明其市盈率的合理性，Vita Coco Company 需要產生遠超市場的卓越增長。</p>
<p>如果我們回顧過去一年的盈利增長，公司實現了 16% 的顯著增長。最近三年期間，EPS 也實現了 835% 的整體增長，這得益於其短期表現。因此，股東們可能會歡迎這些中期的盈利增長率。</p>
<p>展望未來，十位分析師預計未來三年每年將實現 19% 的增長。市場預計每年僅能提供 11% 的增長，因此公司有望實現更強勁的盈利結果。</p>
<p>根據這些信息，我們可以看到為什麼 Vita Coco Company 的市盈率相較於市場如此之高。顯然，股東們不願意拋售可能瞄準更繁榮未來的股票。</p>
<h2>最後總結</h2>
<p>Vita Coco Company 的市盈率像其股票在過去一個月一樣高漲。我們認為市盈率的作用主要不是作為估值工具，而是用來衡量當前投資者情緒和未來預期。</p>
<p>正如我們所懷疑的，我們對 Vita Coco Company 的分析師預測的審查顯示，其優越的盈利前景正在推動其高市盈率。在這種情況下，投資者認為盈利惡化的潛力不足以證明降低市盈率的合理性。在這種情況下，很難看到股價在近期內大幅下跌。</p>
<p>公司的資產負債表中可能存在許多潛在風險。查看我們對 Vita Coco Company 的 <strong>免費</strong> 資產負債表分析，其中包含對一些關鍵因素的六項簡單檢查。</p>
<p>你可能會找到比 Vita Coco Company 更好的投資。如果你想要一些可能的候選者，請查看這份 <strong>免費</strong> 的低市盈率且已證明能夠增長盈利的有趣公司名單。</p>

COCO

<p>Vita Coco 公司（NASDAQ:COCO）的股票在過去一個月上漲了 25%，在過去一年上漲了 50%。儘管其市盈率高達 44 倍，超過市場平均水平，但公司強勁的盈利增長和積極的未來展望證明了這一估值是合理的。分析師預測未來三年年均增長率將達到 19%，超過市場的 11% 預測。投資者對公司的未來保持樂觀，這也推動了其高市盈率</p>

<p>Despite an already strong run, <strong>The Vita Coco Company, Inc.</strong> (NASDAQ:COCO) shares have been powering on, with a gain of 25% in the last thirty days. Looking back a bit further, it's encouraging to see the stock is up 50% in the last year.</p>
<div class="lb-trans"><p>儘管已經有了強勁的表現，<strong>Vita Coco Company, Inc.</strong>（納斯達克代碼：COCO）的股票仍在持續上漲，過去三十天上漲了 25%。回顧更長的時間段，令人鼓舞的是，過去一年該股票上漲了 50%。</p>
</div><p>Following the firm bounce in price, given close to half the companies in the United States have price-to-earnings ratios (or &#34;P/E's&#34;) below 18x, you may consider Vita Coco Company as a stock to avoid entirely with its 44x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.</p>
<div class="lb-trans"><p>在價格大幅反彈後，考慮到美國近一半的公司市盈率（或稱&#34;P/E&#34;）低於 18 倍，你可能會考慮完全避免投資 Vita Coco Company，因為其市盈率為 44 倍。不過，僅僅根據市盈率來判斷並不明智，因為可能有解釋其如此高的原因。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p>With earnings growth that's superior to most other companies of late, Vita Coco Company has been doing relatively well. The P/E is probably high because investors think this strong earnings performance will continue. If not, then existing shareholders might be a little nervous about the viability of the share price.</p>
<div class="lb-trans"><p>Vita Coco Company 的盈利增長優於最近大多數其他公司，表現相對良好。市盈率之所以可能較高，是因為投資者認為這種強勁的盈利表現將會持續。如果不是，那麼現有股東可能會對股價的可持續性感到有些緊張。</p>
</div><p>See our latest analysis for Vita Coco Company</p>
<div class="lb-trans"><p>查看我們對 Vita Coco Company 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/29328309-pe-multiple-vs-industry-1-dark-2/1764505189784" alt="" original-src="https://images.simplywall.st/asset/chart/29328309-pe-multiple-vs-industry-1-dark-2/1764505189784"/></p>
<p>NasdaqGS:COCO Price to Earnings Ratio vs Industry November 30th 2025</p>
<div class="lb-trans"><p>納斯達克 GS:COCO 市盈率與行業比較 2025 年 11 月 30 日</p>
</div><p>Keen to find out how analysts think Vita Coco Company's future stacks up against the industry? In that case, our <strong>free</strong> report is a great place to start.</p>
<div class="lb-trans"><p>想知道分析師如何看待 Vita Coco Company 的未來與行業的對比嗎？在這種情況下，我們的 <strong>免費</strong> 報告是一個很好的起點。</p>
</div><h2>What Are Growth Metrics Telling Us About The High P/E?</h2>
<div class="lb-trans"><h2>增長指標告訴我們關於高市盈率的什麼？</h2>
</div><p>In order to justify its P/E ratio, Vita Coco Company would need to produce outstanding growth well in excess of the market.</p>
<div class="lb-trans"><p>為了證明其市盈率的合理性，Vita Coco Company 需要產生遠超市場的卓越增長。</p>
</div><p>If we review the last year of earnings growth, the company posted a terrific increase of 16%. The latest three year period has also seen an excellent 835% overall rise in EPS, aided by its short-term performance. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.</p>
<div class="lb-trans"><p>如果我們回顧過去一年的盈利增長，公司實現了 16% 的顯著增長。最近三年期間，EPS 也實現了 835% 的整體增長，這得益於其短期表現。因此，股東們可能會歡迎這些中期的盈利增長率。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 19% per year as estimated by the ten analysts watching the company. With the market only predicted to deliver 11% each year, the company is positioned for a stronger earnings result.</p>
<div class="lb-trans"><p>展望未來，十位分析師預計未來三年每年將實現 19% 的增長。市場預計每年僅能提供 11% 的增長，因此公司有望實現更強勁的盈利結果。</p>
</div><p>With this information, we can see why Vita Coco Company is trading at such a high P/E compared to the market. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.</p>
<div class="lb-trans"><p>根據這些信息，我們可以看到為什麼 Vita Coco Company 的市盈率相較於市場如此之高。顯然，股東們不願意拋售可能瞄準更繁榮未來的股票。</p>
</div><h2>The Final Word</h2>
<div class="lb-trans"><h2>最後總結</h2>
</div><p>Vita Coco Company's P/E is flying high just like its stock has during the last month. We'd say the price-to-earnings ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.</p>
<div class="lb-trans"><p>Vita Coco Company 的市盈率像其股票在過去一個月一樣高漲。我們認為市盈率的作用主要不是作為估值工具，而是用來衡量當前投資者情緒和未來預期。</p>
</div><p>As we suspected, our examination of Vita Coco Company's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. It's hard to see the share price falling strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>正如我們所懷疑的，我們對 Vita Coco Company 的分析師預測的審查顯示，其優越的盈利前景正在推動其高市盈率。在這種情況下，投資者認為盈利惡化的潛力不足以證明降低市盈率的合理性。在這種情況下，很難看到股價在近期內大幅下跌。</p>
</div><p>A lot of potential risks can sit within a company's balance sheet. Take a look at our <strong>free</strong> balance sheet analysis for Vita Coco Company with six simple checks on some of these key factors.</p>
<div class="lb-trans"><p>公司的資產負債表中可能存在許多潛在風險。查看我們對 Vita Coco Company 的 <strong>免費</strong> 資產負債表分析，其中包含對一些關鍵因素的六項簡單檢查。</p>
</div><p>You might be able to find a better investment than Vita Coco Company. If you want a selection of possible candidates, check out this <strong>free</strong> list of interesting companies that trade on a low P/E (but have proven they can grow earnings).</p>
<div class="lb-trans"><p>你可能會找到比 Vita Coco Company 更好的投資。如果你想要一些可能的候選者，請查看這份 <strong>免費</strong> 的低市盈率且已證明能夠增長盈利的有趣公司名單。</p>
</div>

Vita Coco 公司（納斯達克股票代碼：COCO）的股價上漲了 25%，但其市盈率仍然看起來合理